Clinical Study On Treatment Of Mild Moderate Heart Failure With Ventricular Premature Beat By

Purpose:Changes to the24-hour dynamic electrocardiogram room in early times as the main research the end. Main evaluation of traditional Chinese medicine and shensong yangxin capsule in patients with chronic heart failure with ventricular premature beat the influence of the number of premature beat, at the same time, evaluation and shensong yangxin capsule indexes of cardiac function and quality of life in patients with chronic heart failure, in order to combine traditional Chinese and western medicine treatment of chronic heart failure with ventricular premature beat to provide clinical basis.Material and method:According to randomized, controlled trial design principle, the60cases of clinical patients with mild heart failure with ventricular premature beat, randomly divided into two groups:treatment group and control group,30cases in each group. The treatment group given standardized treatment+"shensong yangxin capsule" chronic heart failure. The control group given standardized treatment chronic heart failure simulation agent+"shensong yangxin capsule".3months after treatment, observing24hours dynamic electrocardiogram (ecg) in the room early times; The change of NYHA heart function classification. Echocardiography to detect left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVED) changes; Serum NT-proBNP changes; Based on changes in heart rate.Results:1. Treatment group in treating ventricular premature beat has good effect, after statistics analysis, decreased frequency of premature ventricular rate is higher than the control group (P <0.05), statistically significant, the treatment group in the treatment of ventricular premature beat effect is more effective than the control group; 2. The treatment group on the heart rate change is better than that of control group (P<0.05), with statistical significance;3. Treatment group and control group also had an improved left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVED) changes of serum NT-proBNP change, after statistics analysis, the treatment group is better than that of control group (P<0.05).Conclusion:1.shensong yangxin capsule has obvious effect to the treatment of ventricular premature beat.2.shensong yangxin capsule could improve the rate of chronic heart failure.3. shensong yangxin capsule on chronic heart failure in ejection fraction, left ventricular end-diastolic diameter have improvement action...